Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

SBI-0640756 is an inhibitor of eukaryotic translation initiation factor 4 gamma 1 (eIF4G1).1 It inhibits the association of eIF4G1 with the eIF4F complex in UACC-903 melanoma cell lysates in an m7GTP-agarose pull-down assay when used at a concentration of 0.75 µM. SBI-0640756 also inhibits eIF4G1-dependent and -independent mRNA translation in reporter assays using rabbit reticulocyte lysates (IC50s = 3.83 and 4.59 µM, respectively). It reduces the growth of 1205Lu, WM1346, A375, UACC-903, and WM3629 melanoma cells in a concentration-dependent manner. SBI-0640756 (0.5 mg/kg) decreases tumor incidence by 50% in an N-RasQ61K-expressing, Ink4a-/- murine melanoma model. It also decreases tumor volume in an A375 mouse xenograft model when used in combination with the B-RAFV600E inhibitor PLX4720 (Item No. 15142).
WARNING This product is not for human or veterinary use.
1. SBI-